SAN MATEO, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)PHARMACEUTICAL AND BIOSCIENCE SOCIETY INTERNATIONAL, founded in 2007, is a small nonprofit that reported $720K in total revenue in fiscal year 2023. Revenue surged 165% from the prior year, signaling strong growth momentum. The organization ran a surplus of $180K, a strong 25% operating margin.
TO PROMOTE THE EXCHANGE OF SCIENTIFIC AND TECHNICAL IDEAS, AND TO PROVIDE EDUCATIONAL AND GROWTH OPPORTUNITIES IN THE FIELDS OF ANALYTICAL CHEMISTRY, DRUG MATABOLISM, PHARMACOKINETICS AND RELATED DISCIPLINES. WE FOSTER INTERACTIONS AND DISSEMINATE INFORMATION THORUGH SEMINAR LUNCHEONS, TERGETED WORKSHOPS, EXPERT FORUMS, VENDOR SHOWS AND JOB OPENINGS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $720,000 | $272,121 | +1.6% |
| Expenses | $539,658 | $112,776 | +3.8% |
| Net Income | $180,342 | $159,345 | +0.1% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| SHICHANG MIAO | PRESIDENT/CEO | 2.00 |
Director
|
$0 | $0 | $0 |
| ROBYN ROURICK | SECRETARY | 2.00 |
Director
|
$0 | $0 | $0 |
| DAVE TOMAN | TREASURER | 2.00 |
Director
|
$0 | $0 | $0 |
| SAM SPERRY | MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| JENNIFER YANG | MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| JIM ZHANG | MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| JING-TAO WU | MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| KARUPPIAH KANNAN | MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| CHANDRA PRAKASH | MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| JOHN LANGLANDS | MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| RENEE MOSI | MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| WALTER KORZ | MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $720,000 | $539,658 | $679,098 | $180,342 |
| 2023 | $272,121 | $112,776 | $498,756 | $159,345 |
| 2022 | $6,078 | $71,250 | $339,411 | $-65,172 |
| 2021 | $20,930 | $70,497 | $404,583 | $-49,567 |
| 2020 | $231,085 | $251,555 | $454,150 | $-20,470 |
| 2020 | $228,999 | $50,244 | $653,375 | $178,755 |
| 2019 | $310,103 | $271,497 | $474,620 | $38,606 |
| 2018 | $293,228 | $212,367 | $413,096 | $80,861 |
| 2018 | $350,727 | $265,723 | $417,240 | $85,004 |
Compare PHARMACEUTICAL AND BIOSCIENCE SOCIETY INTERNATIONAL with other nonprofits in California and across the country.